iShares iBonds Dec 2035 Term Corporate ETF (IBCA)
Live price chart, market sentiment, and community perspectives for iShares iBonds Dec 2035 Term Corporate ETF (AMEX: IBCA).
Live price chart, market sentiment, and community perspectives for iShares iBonds Dec 2035 Term Corporate ETF (AMEX: IBCA).
Secondary debt liquidity for IBCA proxies remains highly resilient despite headline noise. Watching gross margin expansion.
On our desk, evaluating target-maturity products like IBCA comes down to matching duration profiles with specific macro timelines. With a weighted average maturity of 8.81 years and roughly 99.80% of market value concentrated in the 7-10 year maturity bucket as of August 2026, the fund provides a very clean structural instrument for investors looking to lock in duration without managing an individual bond ladder manually. Sentiment on the desk views the steady monthly income distributions—ranging consistently around $0.099 to $0.104 per share—as a dependable cash-flow mechanism, though market participants must remain cognizant of broader interest-rate volatility.
Looking at the fundamental risk profile of IBCA from a quantitative lens, we note the fund's non-diversified status and its specific exposure to investment-grade corporate debt. Sector allocations show solid diversification across Consumer Non-Cyclical (17.16%), Technology (14.24%), and Electric (10.55%), which helps buffer individual issuer shocks. However, fixed income headwinds remain persistent; as standard market mechanics dictate, any sharp shifts in interest rates directly impact debt security valuations. Furthermore, credit risk remains an inherent vulnerability if underlying corporate issuers face operational distress leading up to the 2035 termination horizon.
When analyzing portfolio construction for clients inquiring about defined-maturity ETFs, I emphasize the operational mechanics highlighted in the fund's prospectus. IBCA mandates that at least 80% of its assets are invested in component instruments of the underlying 2035 corporate bond index, with at least 90% in fixed income securities of that type. For analysts and portfolio managers building structured fixed-income allocations, understanding the exact convexity (reported at 0.56) and distribution yield components—which show zero short-term or long-term capital gains distributions in recent periods—is crucial for accurate tax and cash-flow modeling.
Explore plasma cleansing, somatic organ swaps, and BCI.